CompoAtlas

GOOD.NIGHT

Food supplement declared in France, declaration No 2022-9-122

GOOD.NIGHT (Boticinal Laboratoire) is a food supplement declared in France. Status: retiré du marché le 17 November 2024. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Boticinal Laboratoire
Food business operator placing the product on the market
BOTICINAL
Status
Retiré du marché le 17 November 2024
Form
Gomme
Daily dose
2 gommes par jour
Directions for use
2 gommes par jour, 30 minutes avant le coucher.
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Sous traitement médicamenteux, Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil
Flavourings
Framboise

Declaration 187261, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Passiflora incarnata L.FleurExtrait sec aqueux100 mg
Matricaria chamomilla L.CapituleExtrait sec aqueux40 mg
Melissa officinalis L.FeuilleExtrait sec aqueux40 mg

Other active ingredients

NamePer day
Mélatoninenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Additives

E440, E330, E331, E163, E903

Other ingredients

sirop de glucose, sucre, Huile de coco

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux personnes souffrant de maladies inflammatoires ou auto-immunes; aux femmes enceintes ou allaitantes; aux enfants et adolescents; aux personnes devant réaliser une activité nécessitant une vigilance soutenue et pouvant poser un problème de sécurité en cas de somnolence. Soumettre la consommation de mélatonine à un avis médical pour les personnes épileptiques, les personnes asthmatiques; les personnes souffrant de troubles de l'humeur, du comportement ou de la personnalité; ou les personnes suivant un traitement médicamenteux. Limiter la prise de ce complément alimentaire à un usage ponctuel.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : Boticinal Laboratoire

Enter to analyse, Shift+Enter for a new line